Progyny, Inc. (PGNY)
27.59
+0.24
(+0.88%)
USD |
NASDAQ |
Sep 14, 11:46
Progyny Enterprise Value : 1.907B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.907B |
| September 10, 2026 | 1.886B |
| September 09, 2026 | 1.889B |
| September 08, 2026 | 1.891B |
| September 04, 2026 | 1.798B |
| September 03, 2026 | 1.849B |
| September 02, 2026 | 1.825B |
| September 01, 2026 | 1.776B |
| August 31, 2026 | 1.770B |
| August 28, 2026 | 1.802B |
| August 27, 2026 | 1.791B |
| August 26, 2026 | 1.831B |
| August 25, 2026 | 1.788B |
| August 24, 2026 | 1.760B |
| August 21, 2026 | 1.775B |
| August 20, 2026 | 1.799B |
| August 19, 2026 | 1.766B |
| August 18, 2026 | 1.780B |
| August 17, 2026 | 1.750B |
| August 14, 2026 | 1.824B |
| August 13, 2026 | 1.794B |
| August 12, 2026 | 1.757B |
| August 11, 2026 | 1.846B |
| August 10, 2026 | 1.945B |
| August 07, 2026 | 1.965B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.128B |
| August 05, 2026 | 2.218B |
| August 04, 2026 | 2.226B |
| August 03, 2026 | 2.230B |
| July 31, 2026 | 2.199B |
| July 30, 2026 | 2.227B |
| July 29, 2026 | 2.218B |
| July 28, 2026 | 2.171B |
| July 27, 2026 | 2.235B |
| July 24, 2026 | 2.204B |
| July 23, 2026 | 2.166B |
| July 22, 2026 | 2.216B |
| July 21, 2026 | 2.285B |
| July 20, 2026 | 2.249B |
| July 17, 2026 | 2.261B |
| July 16, 2026 | 2.256B |
| July 15, 2026 | 2.293B |
| July 14, 2026 | 2.294B |
| July 13, 2026 | 2.265B |
| July 10, 2026 | 2.162B |
| July 09, 2026 | 2.195B |
| July 08, 2026 | 2.171B |
| July 07, 2026 | 2.172B |
| July 06, 2026 | 2.184B |
| July 02, 2026 | 2.129B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DaVita, Inc. | 25.14B |
| Lifestance Health Group, Inc. | 5.203B |
| Acadia Healthcare Co., Inc. | 5.184B |
| U.S. Physical Therapy, Inc. | 1.854B |
| Quest Diagnostics, Inc. | 31.99B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 28.05M |
| Revenue (Quarterly) | 350.51M |
| Total Expenses (Quarterly) | 322.46M |
| EPS Diluted (Quarterly) | 0.3415 |
| Gross Profit Margin (Quarterly) | 25.48% |
| Profit Margin (Quarterly) | 8.00% |
| Earnings Yield | 3.34% |
| Operating Earnings Yield | 4.69% |
| Normalized Earnings Yield | 3.337 |